Dr Thomas Park is a neuroscientist specialising in brain tumour research. His team at the Centre for Brain Research, University of Auckland, investigates brain tumour biology using brain tumour tissues and cells donated from neurosurgery. He collaborates with a wide range of clinical and scientific experts to work on project involving, 1) brain tumour drug development, 2) personalised digital diagnostics, 3) radiation neuro-biology, and 4) establishing a national brain tumour registry.

Dr Catherine Han is a New Zealand-trained medical oncologist specialising in neuro-oncology, gastrointestinal, breast, head and neck cancers, and ocular melanoma. As co-chair (clinical) and treasurer of NANOS, she played a pivotal role in its establishment in 2023. Through a Health Research Council of New Zealand (HRC) Clinical Research Training Fellowship, she pursued a PhD degree and clinical research training. Furthering her expertise in neuro-oncology, she underwent specialised training at Massachusetts General Hospital of Harvard Medical School in 2016. Currently, Dr Han serves as a consultant medical oncologist and co-director at Auckland Oncology, while also holding a Senior Lecturer position at the University of Auckland. She actively contributes to the Auckland Medical School and conducts clinical trials through the University of Auckland and New Zealand Clinical Research. Dr Han is an Executive Board member of the Asian Societies of Neuro-Oncology (ASNO), representing New Zealand, and a member of several prominent oncology societies worldwide.

Dr Dean Singleton is a cancer biologist based at the Auckland Cancer Society Research Centre, University of Auckland. His research focuses on IDH1 mutant glioma and the application of functional genomics to identify novel targets in this setting.

Caroline Woon is a Clinical Nurse Specialist in neurosurgery at Wellington Hospital.  She is passionate about the care of the neurosurgical patient through their journey and using research to enhance their care!  She organises conferences for nurses in New Zealand and Australasia through NZ Neuro Nurses and Australasian Neuroscience Nurses Association (ANNA).  She is on the board for Brain Tumour Support and now the NANOS committee to support collaboration amongst health professionals, researchers and scientists to enhance the care of patients in the field of Neuro Oncology.

Dr Fouzia Ziad is a consultant pathologist at Te Whatu Ora Waikato Hospital Laboratories with a special interest in neuro-oncology. Her research projects involve neuro-oncology including meningiomas. She is also current the President of Australian and New Zealand Society of Neuropathology (ANZSNP).

Dr Tania Slatter is an Associate Professor at Otago University and is Director of the Medical Laboratory Science within the Department of Pathology. Her research is centred around how cellular damage contributes to cancer development, progression and treatment resistance with an emphasis on brain cancers. Her research also contributes into translational projects that combine aspects of pathology, neurosurgery, radiology and oncology to improve the outcome of those with brain cancer.

Dr Melissa James is a radiation oncologist practising in Christchurch, New Zealand. Her specialty interests lie in the use of radiation for palliation and in the treatment of breast cancer, brain tumours and melanoma. Her current focus is advocating for adequate workforce and facilities to improve access to radiation treatment within New Zealand. She has been involved with teaching and training registrars and is passionate about training the new generation of radiation oncologists. She is also passionate about improving patient outcomes and has been involved in the introduction of new technology to improve radiation techniques for brain tumour patients.

Dr Susan Li is a neuroscientist based at the Centre for Brain Research, University of Auckland. She is especially interested in neuro-oncology and works in collaboration with Dr Thomas Park to study brain tumour biology.